IDEAS home Printed from https://ideas.repec.org/a/spr/pharme/v37y2019i8d10.1007_s40273-019-00801-9.html
   My bibliography  Save this article

Accounting for Capacity Constraints in Economic Evaluations of Precision Medicine: A Systematic Review

Author

Listed:
  • Stuart J. Wright

    (The University of Manchester)

  • William G. Newman

    (The University of Manchester
    Manchester University NHS Foundation Trust)

  • Katherine Payne

    (The University of Manchester)

Abstract

Background and Objective Precision (stratified or personalised) medicine is underpinned by the premise that it is feasible to identify known heterogeneity using a specific test or algorithm in patient populations and to use this information to guide patient care to improve health and well-being. This study aimed to understand if, and how, previous economic evaluations of precision medicine had taken account of the impact of capacity constraints. Methods A meta-review was conducted of published systematic reviews of economic evaluations of precision medicine (test–treat interventions) and individual studies included in these reviews. Due to the volume of studies identified, a sample of papers published from 2007 to 2015 was collated. A narrative analysis identified whether potential capacity constraints were discussed qualitatively in the studies and, if relevant, which quantitative methods were used to account for capacity constraints. Results A total of 45 systematic reviews of economic evaluations of precision medicine were identified, from which 222 studies focusing on test–treat interventions, published between 2007 and 2015, were extracted. Of these studies, 33 (15%) qualitatively discussed the potential impact of capacity constraints, including budget constraints; quality of tests and the testing process; ease of use of tests in clinical practice; and decision uncertainty. Quantitative methods (nine studies) to account for capacity constraints included static methods such as capturing inefficiencies in trials or models and sensitivity analysis around model parameters; and dynamic methods, which allow the impact of capacity constraints on cost effectiveness to change over time. Conclusions Understanding the cost effectiveness of precision medicine is necessary, but not sufficient, evidence for its successful implementation. There are currently few examples of evaluations that have quantified the impact of capacity constraints, which suggests an area of focus for future research.

Suggested Citation

  • Stuart J. Wright & William G. Newman & Katherine Payne, 2019. "Accounting for Capacity Constraints in Economic Evaluations of Precision Medicine: A Systematic Review," PharmacoEconomics, Springer, vol. 37(8), pages 1011-1027, August.
    • Handle: RePEc:spr:pharme:v:37:y:2019:i:8:d:10.1007_s40273-019-00801-9
    DOI: 10.1007/s40273-019-00801-9
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40273-019-00801-9
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40273-019-00801-9?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Phillips Kathryn A. & Sakowski Julie Ann & Liang Su-Ying & Ponce Ninez A., 2013. "Economic Perspectives on Personalized Health Care and Prevention," Forum for Health Economics & Policy, De Gruyter, vol. 16(2), pages 23-52, June.
    2. Adang, Eddy & Voordijk, Leo & Jan van der Wilt, Gert & Ament, Andre, 2005. "Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions," Health Policy, Elsevier, vol. 74(2), pages 146-156, October.
    3. Alan Brennan & Stephen E. Chick & Ruth Davies, 2006. "A taxonomy of model structures for economic evaluation of health technologies," Health Economics, John Wiley & Sons, Ltd., vol. 15(12), pages 1295-1310, December.
    4. Jane J Kim & Joshua A Salomon & Milton C Weinstein & Sue J Goldie, 2006. "Packaging Health Services When Resources Are Limited: The Example of a Cervical Cancer Screening Visit," PLOS Medicine, Public Library of Science, vol. 3(11), pages 1-8, November.
    5. Carlo Barone & Carmine Pinto & Nicola Normanno & Lorenzo Capussotti & Francesco Cognetti & Alfredo Falcone & Lorenzo Mantovani, 2014. "KRAS Early Testing: Consensus Initiative and Cost-Effectiveness Evaluation for Metastatic Colorectal Patients in an Italian Setting," PLOS ONE, Public Library of Science, vol. 9(1), pages 1-13, January.
    6. Anders Chen & David W Dowdy, 2014. "Clinical Effectiveness and Cost-Effectiveness of HIV Pre-Exposure Prophylaxis in Men Who Have Sex with Men: Risk Calculators for Real-World Decision-Making," PLOS ONE, Public Library of Science, vol. 9(10), pages 1-9, October.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Bernhard Ultsch & Oliver Damm & Philippe Beutels & Joke Bilcke & Bernd Brüggenjürgen & Andreas Gerber-Grote & Wolfgang Greiner & Germaine Hanquet & Raymond Hutubessy & Mark Jit & Mirjam Knol & Rüdiger, 2016. "Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community," PharmacoEconomics, Springer, vol. 34(3), pages 227-244, March.
    2. Becky Pennington & Alex Filby & Lesley Owen & Matthew Taylor, 2018. "Smoking Cessation: A Comparison of Two Model Structures," PharmacoEconomics, Springer, vol. 36(9), pages 1101-1112, September.
    3. Peter J. Dodd & Jeff J. Pennington & Liza Bronner Murrison & David W. Dowdy, 2018. "Simple Inclusion of Complex Diagnostic Algorithms in Infectious Disease Models for Economic Evaluation," Medical Decision Making, , vol. 38(8), pages 930-941, November.
    4. Jonathan Karnon & James Stahl & Alan Brennan & J. Jaime Caro & Javier Mar & Jörgen Möller, 2012. "Modeling Using Discrete Event Simulation," Medical Decision Making, , vol. 32(5), pages 701-711, September.
    5. Adang, Eddy M.M. & Wensing, Michel, 2008. "Economic barriers to implementation of innovations in health care: Is the long run-short run efficiency discrepancy a paradox?," Health Policy, Elsevier, vol. 88(2-3), pages 236-242, December.
    6. Arielle Anderer & Hamsa Bastani & John Silberholz, 2022. "Adaptive Clinical Trial Designs with Surrogates: When Should We Bother?," Management Science, INFORMS, vol. 68(3), pages 1982-2002, March.
    7. Eren Demir & David Southern, 2017. "Enabling better management of patients: discrete event simulation combined with the STAR approach," Journal of the Operational Research Society, Palgrave Macmillan;The OR Society, vol. 68(5), pages 577-590, May.
    8. Nadia Demarteau & Thomas Breuer & Baudouin Standaert, 2012. "Selecting a Mix of Prevention Strategies against Cervical Cancer for Maximum Efficiency with an Optimization Program," PharmacoEconomics, Springer, vol. 30(4), pages 337-353, April.
    9. Jen Kruger & Daniel Pollard & Hasan Basarir & Praveen Thokala & Debbie Cooke & Marie Clark & Rod Bond & Simon Heller & Alan Brennan, 2015. "Incorporating Psychological Predictors of Treatment Response into Health Economic Simulation Models," Medical Decision Making, , vol. 35(7), pages 872-887, October.
    10. Sarah Bates & Thomas Bayley & Paul Norman & Penny Breeze & Alan Brennan, 2020. "A Systematic Review of Methods to Predict Weight Trajectories in Health Economic Models of Behavioral Weight-Management Programs: The Potential Role of Psychosocial Factors," Medical Decision Making, , vol. 40(1), pages 90-105, January.
    11. F. Tomini & F. Prinzen & A. D. I. Asselt, 2016. "A review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failure," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(9), pages 1159-1172, December.
    12. Luis Hernandez & Asli Ozen & Rodrigo DosSantos & Denis Getsios, 2016. "Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer’s Disease," PharmacoEconomics, Springer, vol. 34(7), pages 681-707, July.
    13. Sarang Deo & Sameer Mehta & Charles J. Corbett, 2022. "Optimal Scale‐Up of HIV Treatment Programs in Resource‐Limited Settings Under Supply Uncertainty," Production and Operations Management, Production and Operations Management Society, vol. 31(3), pages 883-905, March.
    14. Matthew J. Glover & Edmund Jones & Katya L. Masconi & Michael J. Sweeting & Simon G. Thompson, 2018. "Discrete Event Simulation for Decision Modeling in Health Care: Lessons from Abdominal Aortic Aneurysm Screening," Medical Decision Making, , vol. 38(4), pages 439-451, May.
    15. Caroline Canavan & Joe West & Timothy Card, 2016. "Calculating Total Health Service Utilisation and Costs from Routinely Collected Electronic Health Records Using the Example of Patients with Irritable Bowel Syndrome Before and After Their First Gastr," PharmacoEconomics, Springer, vol. 34(2), pages 181-194, February.
    16. Caroline Canavan & Joe West & Timothy Card, 2016. "Calculating Total Health Service Utilisation and Costs from Routinely Collected Electronic Health Records Using the Example of Patients with Irritable Bowel Syndrome Before and After Their First Gastr," PharmacoEconomics, Springer, vol. 34(2), pages 181-194, February.
    17. L. B. Standfield & T. A. Comans & P. A. Scuffham, 2017. "An empirical comparison of Markov cohort modeling and discrete event simulation in a capacity-constrained health care setting," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(1), pages 33-47, January.
    18. Emma McManus & Tracey Sach & Nick Levell, 2018. "The Use of Decision–Analytic Models in Atopic Eczema: A Systematic Review and Critical Appraisal," PharmacoEconomics, Springer, vol. 36(1), pages 51-66, January.
    19. Marion Rauner & Michaela Schaffhauser-Linzatti & Helmut Niessner, 2012. "Resource planning for ambulance services in mass casualty incidents: a DES-based policy model," Health Care Management Science, Springer, vol. 15(3), pages 254-269, September.
    20. Mehdi Najafzadeh & Carlo A Marra & Larry D Lynd & Mohsen Sadatsafavi & J Mark FitzGerald & Bruce McManus & Don Sin, 2012. "Future Impact of Various Interventions on the Burden of COPD in Canada: A Dynamic Population Model," PLOS ONE, Public Library of Science, vol. 7(10), pages 1-12, October.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:37:y:2019:i:8:d:10.1007_s40273-019-00801-9. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.